A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis
Revista Espanola de Enfermedades Digestivas
The treatment of severe ulcerative colitis (UC) flares includes measures such as hospitalization and intravenous steroids. Despite this, a quarter of patients are refractory to treatment. Given the availability of new therapeutic strategies in patients with steroid-refractory UC (cyclosporine, infliximab, apheresis, surgery) it is necessary to predict which treatment will be most effective for each patient. To determine which clinical or biological factors discriminate the lack of response topmid:19388796 fatcat:yn2sw2mjnzfrpebrd4hfzdwhiq